医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

BIO Joins Coalition Cautioning Against Further Restructuring of Japan’s Pharmaceutical Pricing Structure

2015年07月29日 PM10:57
このエントリーをはてなブックマークに追加


 

WASHINGTON

Today BIO joined a coalition of organizations urging the Government of Japan to maintain the established reimbursement pricing structure for pharmaceuticals and medical devices.

While the Abe Administration continues to take impressive steps to promote the domestic and foreign innovative healthcare industry in Japan over the past several years, its proposal to change the schedule for reimbursement pricing to an annual system poses a danger to investment and innovation across the entire healthcare spectrum. Such a change would impede innovation and delay access by Japanese patients to lifesaving and enhancing healthcare innovation.

The current biennial repricing system has effectively controlled costs for over two decades and provided Japanese patients with early access to the newest and most innovative medical technologies being developed around the world. This proposal would counter Prime Minister Abe’s ongoing efforts to strengthen the Japanese economy and promote a vibrant healthcare industry.

BIO shares this position with our coalition partners: the American Chamber of Commerce in Japan (ACCJ), the European Business Council (EBC), the American Medical Devices and Diagnostics Manufacturers’ Association (AMDD), the Advanced Medical Technology Association (AdvaMed), the Pharmaceutical Research and Manufacturers of America (PhRMA), the European Federation of Pharmaceutical Industries and Associations (EFPIA).

For More Information, Read the Joint Statement

About BIO

BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO’s blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

Upcoming BIO Events

BIO Latin America Conference
October 14-16, 2015
Rio de Janeiro, Brazil

BIO Investor Forum
October 20-21, 2015
San Francisco, CA

BIO-Europe
November 2-4, 2015
Munich, Germany

View source version on businesswire.com: http://www.businesswire.com/news/home/20150729006031/en/

CONTACT

BIO
George Goodno, 202-962-6660
Web:
www.bio.org
Blog:
www.biotech-now.org
Twitter:
@IAmBiotech

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Brightree发布面向居家医疗器械的首个患者App
  • Brightreeが初のHME向け患者アプリを発表
  • Takeda to Present Results from Phase 3 ALTA-1L Trial Highlighting Intracranial Efficacy of ALUNBRIG® (brigatinib) Versus Crizotinib in First-Line Advanced ALK+ Non-Small Cell Lung Cancer
  • ポットネットワーク・ホールディングスがSEC報告会社登録に基づきPCAOB監査人による完全な監査・レビュー済みの財務報告書を公表
  • Takeda Receives Clearance from the Japan Fair Trade Commission for the Proposed Acquisition of Shire plc